{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:42:26Z","timestamp":1792788146898,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.msard.2026.107948","type":"journal-article","created":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T15:29:47Z","timestamp":1790436587000},"page":"107948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Deconstructing the microbiota\u2013gut\u2013brain axis in multiple sclerosis: from a barrier\u2013immune\u2013metabolic framework to emerging therapeutics"],"prefix":"10.1016","volume":"115","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-9023-1690","authenticated-orcid":false,"given":"Jinxi","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangxiong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-0881","authenticated-orcid":false,"given":"Zhongxin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.msard.2026.107948_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2013.03.013","article-title":"Pleiotropic roles of bile acids in metabolism","volume":"17","author":"Aguiar Vallim","year":"2013","journal-title":"Cell Metab."},{"issue":"2","key":"10.1016\/j.msard.2026.107948_bib2","article-title":"Fecal microbiota transplantation is safe and tolerable in patients with multiple sclerosis: a pilot randomized controlled trial","volume":"8","author":"Al","year":"2022","journal-title":"Mult. Scler. J. Exp. Transl. Clin."},{"issue":"7_Supplement_1","key":"10.1016\/j.msard.2026.107948_bib3","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000212332","article-title":"The impact of gut microbiota modulation on disease progression and symptom management in multiple sclerosis (P12-1.004)","volume":"104","author":"Anani","year":"2025","journal-title":"Neurology"},{"issue":"7480","key":"10.1016\/j.msard.2026.107948_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/nature12726","article-title":"Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation","volume":"504","author":"Arpaia","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.msard.2026.107948_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.phymed.2018.06.017","article-title":"Achillea millefolium is beneficial as an add-on therapy in patients with multiple sclerosis: a randomized placebo-controlled clinical trial","volume":"52","author":"Ayoobi","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s40795-025-01156-5","article-title":"Fasting, ketogenic, and anti-inflammatory diets in multiple sclerosis: a randomized controlled trial with 18-month follow-up","volume":"11","author":"Bahr","year":"2025","journal-title":"BMC Nutr."},{"key":"10.1016\/j.msard.2026.107948_bib7","series-title":"Diet and Nutrition in Neurological Disorders","first-page":"557","article-title":"Linking diet and gut microbiota in multiple sclerosis","author":"Bitarafan","year":"2023"},{"key":"10.1016\/j.msard.2026.107948_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1176016","article-title":"Feeding the gut microbiome: impact on multiple sclerosis","volume":"14","author":"Bronzini","year":"2023","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2026.107948_bib9","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1177\/1352458520928301","article-title":"Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis","volume":"27","author":"Brown","year":"2021","journal-title":"Mult. Scler"},{"key":"10.1016\/j.msard.2026.107948_bib10","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fneur.2020.00150","article-title":"Beyond metabolism: the complex interplay between dietary phytoestrogens, gut bacteria, and cells of nervous and immune systems","volume":"11","author":"Cady","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107948_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103798","article-title":"Alterations of host-gut microbiome interactions in multiple sclerosis","volume":"76","author":"Cantoni","year":"2022","journal-title":"EBioMedicine"},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2025.2576657","article-title":"Unraveling multiple sclerosis: a hidden interaction between intestinal microbiota and host lipid metabolism","volume":"17","author":"Cen","year":"2025","journal-title":"Gut. Microbes"},{"issue":"13","key":"10.1016\/j.msard.2026.107948_bib13","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1242\/jcs.114.13.2363","article-title":"p300\/CBP proteins: HATs for transcriptional bridges and scaffolds","volume":"114","author":"Chan","year":"2001","journal-title":"J. Cell Sci."},{"issue":"5","key":"10.1016\/j.msard.2026.107948_bib14","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrm1368","article-title":"Shaping the nuclear action of NF-\u03baB","volume":"5","author":"Chen","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.msard.2026.107948_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104675","article-title":"Human gut microbiota and its association with pathogenesis and treatments of neurodegenerative diseases","volume":"150","author":"Chen","year":"2021","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.msard.2026.107948_bib16","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8168717","article-title":"Gut microbiota in multiple sclerosis and experimental autoimmune encephalomyelitis: current applications and future perspectives","volume":"2018","author":"Chu","year":"2018","journal-title":"Mediators. Inflamm."},{"issue":"9","key":"10.1016\/j.msard.2026.107948_bib17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/s41582-022-00697-8","article-title":"The role of the gut microbiota in multiple sclerosis","volume":"18","author":"Correale","year":"2022","journal-title":"Nat. Rev. Neurol."},{"issue":"3","key":"10.1016\/j.msard.2026.107948_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000213905","article-title":"Serum alpha-linolenic acid and long-term multiple sclerosis activity and progression","volume":"105","author":"Cortese","year":"2025","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.msard.2026.107948_bib19","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700492","article-title":"High frequency of intestinal TH17 cells correlates with microbiota alterations and disease activity in multiple sclerosis","volume":"3","author":"Cosorich","year":"2017","journal-title":"Sci. Adv."},{"issue":"5","key":"10.1016\/j.msard.2026.107948_bib20","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","article-title":"Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1","volume":"146","author":"Dang","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.msard.2026.107948_bib21","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fmicb.2011.00166","article-title":"Modulation of mucosal immune response, tolerance, and proliferation in mice colonized by the mucin-degrader Akkermansia muciniphila","volume":"2","author":"Derrien","year":"2011","journal-title":"Front. Microbiol."},{"issue":"4","key":"10.1016\/j.msard.2026.107948_bib22","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s11010-024-05077-y","article-title":"Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases","volume":"480","author":"Ding","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"3","key":"10.1016\/j.msard.2026.107948_bib23","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3390\/brainsci15030253","article-title":"Unveiling the important role of gut microbiota and diet in multiple sclerosis","volume":"15","author":"D\u017eidi\u0107 Krivi\u0107","year":"2025","journal-title":"Brain Sci."},{"issue":"22","key":"10.1016\/j.msard.2026.107948_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214478","article-title":"Probiotics and commensal gut microbiota as the effective alternative therapy for multiple sclerosis patients treatment","volume":"23","author":"Dziedzic","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2026.107948_bib25","doi-asserted-by":"crossref","first-page":"114","DOI":"10.15557\/AN.2024.0017","article-title":"Gut\u2013brain connection in multiple sclerosis","volume":"24","author":"Dziuba","year":"2024","journal-title":"Aktualn. Neurol."},{"key":"10.1016\/j.msard.2026.107948_bib26","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3389\/fneur.2020.00978","article-title":"Single-arm, non-randomized, time series, single-subject study of fecal microbiota transplantation in multiple sclerosis","volume":"11","author":"Engen","year":"2020","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107948_bib27","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3389\/fmicb.2019.00740","article-title":"Dietary modulation of intestinal microbiota: future opportunities in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"10","author":"Fan","year":"2019","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41522-025-00787-7","article-title":"Multiple sclerosis patients exhibit oral dysbiosis with decreased early colonizers and lower hypotaurine level","volume":"11","author":"Fitzjerrells","year":"2025","journal-title":"NPJ Biofilms. Microbiomes."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s13311-017-0588-x","article-title":"The \"gut feeling\": breaking down the role of gut microbiome in multiple sclerosis","volume":"15","author":"Freedman","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"7480","key":"10.1016\/j.msard.2026.107948_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature12721","article-title":"Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells","volume":"504","author":"Furusawa","year":"2013","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.msard.2026.107948_bib31","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/acn3.70212","article-title":"Relapsing\u2013remitting multiple sclerosis is associated with a dysbiotic oral microbiome","volume":"13","author":"Ganesan","year":"2026","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"13","key":"10.1016\/j.msard.2026.107948_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143774","article-title":"Targeting the gut to treat multiple sclerosis","volume":"131","author":"Ghezzi","year":"2021","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.msard.2026.107948_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1635833","article-title":"Efficacy and safety of Chinese herbal medicine for multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials","volume":"16","author":"Guan","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.msard.2026.107948_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2022.104661","article-title":"Hsp65-producing lactococcus lactis inhibits experimental autoimmune encephalomyelitis by preventing cell migration into spinal cord","volume":"384","author":"Guimar\u00e3es","year":"2023","journal-title":"Cell. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib35","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/nri3785","article-title":"Periodontitis: from microbial immune subversion to systemic inflammation","volume":"15","author":"Hajishengallis","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2026.107948_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.neuroscience.2024.05.013","article-title":"The role of intestinal microbiota and probiotics supplementation in multiple sclerosis management","volume":"551","author":"Hasaniani","year":"2024","journal-title":"Neuroscience"},{"issue":"7","key":"10.1016\/j.msard.2026.107948_bib37","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/biomedicines12071392","article-title":"Multiple sclerosis and Clostridium perfringens epsilon toxin: is there a relationship?","volume":"12","author":"Huss","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.msard.2026.107948_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12015","article-title":"Alterations of the human gut microbiome in multiple sclerosis","volume":"7","author":"Jangi","year":"2016","journal-title":"Nat. Commun."},{"issue":"21","key":"10.1016\/j.msard.2026.107948_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2506777122","article-title":"Immune perturbation by the ileal microbiota in multiple sclerosis","volume":"122","author":"Jensen","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msard.2026.107948_bib40","article-title":"Tripterygium glycosides: recent advances in mechanisms, therapeutic applications, and safety optimization","volume":"13","author":"Jin","year":"2026","journal-title":"Front. Med."},{"key":"10.1016\/j.msard.2026.107948_bib41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.12659\/MSM.892764","article-title":"Oral administration of lactococcus lactis expressing synthetic genes of myelin antigens in decreasing experimental autoimmune encephalomyelitis in rats","volume":"21","author":"Kasarello","year":"2015","journal-title":"Med. Sci. Monit."},{"issue":"2","key":"10.1016\/j.msard.2026.107948_bib42","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/13524585221127414","article-title":"Mediterranean diet is linked to less objective disability in multiple sclerosis","volume":"29","author":"Katz Sand","year":"2023","journal-title":"Mult. Scler"},{"issue":"3","key":"10.1016\/j.msard.2026.107948_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/diseases8030033","article-title":"The microbiome as a therapeutic target for multiple sclerosis: can genetically engineered probiotics treat the disease?","volume":"8","author":"Kohl","year":"2020","journal-title":"Diseases"},{"issue":"7","key":"10.1016\/j.msard.2026.107948_bib44","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nri2115","article-title":"Life and death in peripheral T cells","volume":"7","author":"Krammer","year":"2007","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2026.107948_bib45","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2274126","article-title":"Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis","volume":"15","author":"Kujawa","year":"2023","journal-title":"Gut. Microbes"},{"key":"10.1016\/j.msard.2026.107948_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104547","article-title":"The importance of gut\u2013brain axis and use of probiotics as a treatment strategy for multiple sclerosis","volume":"71","author":"Kumar","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107948_bib47","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.590783","article-title":"Alterations of the fecal microbiota in Chinese patients with multiple sclerosis","volume":"11","author":"Ling","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107948_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2023.127440","article-title":"Gut microbes influence the development of central nervous system disorders through epigenetic inheritance","volume":"274","author":"Liu","year":"2023","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.msard.2026.107948_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103109","article-title":"Fecal microbiota transplantation for the management of autoimmune diseases: potential mechanisms and challenges","volume":"141","author":"Liu","year":"2023","journal-title":"J. Autoimmun."},{"issue":"7758","key":"10.1016\/j.msard.2026.107948_bib50","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","article-title":"Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases","volume":"569","author":"Lloyd-Price","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.msard.2026.107948_bib51","doi-asserted-by":"crossref","DOI":"10.1155\/jimr\/6333512","article-title":"From demyelination to intervention: natural compounds as emerging therapeutic targets in multiple sclerosis neuroinflammation","volume":"2026","author":"Long","year":"2026","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.msard.2026.107948_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainresbull.2024.111171","article-title":"Th17\/Treg balance is regulated during the suppression of experimental autoimmune encephalomyelitis treated by Astragalus polysaccharides via the microbiota\u2013gut\u2013brain axis","volume":"220","author":"Ma","year":"2025","journal-title":"Brain Res. Bull."},{"issue":"4","key":"10.1016\/j.msard.2026.107948_bib53","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.immuni.2020.09.016","article-title":"A one-two punch in the gut may trigger multiple sclerosis","volume":"53","author":"Maghzi","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.msard.2026.107948_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2022.1019877","article-title":"Advantages and limitations of experimental autoimmune encephalomyelitis in breaking down the role of the gut microbiome in multiple sclerosis","volume":"15","author":"Melamed","year":"2022","journal-title":"Front. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.msard.2026.107948_bib55","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ane.13045","article-title":"Short-chain fatty acids and gut microbiota in multiple sclerosis","volume":"139","author":"Melbye","year":"2019","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.msard.2026.107948_bib56","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.clim.2017.03.001","article-title":"The gut microbiome and microbial translocation in multiple sclerosis","volume":"183","author":"Mirza","year":"2017","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2026.107948_bib57","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0137429","article-title":"Dysbiosis in the gut microbiota of patients with multiple sclerosis, with a striking depletion of species belonging to Clostridia XIVa and IV clusters","volume":"10","author":"Miyake","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.msard.2026.107948_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.960761","article-title":"Microbial dysbiosis and lack of SCFA production in a Spanish cohort of patients with multiple sclerosis","volume":"13","author":"Moles","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.msard.2026.107948_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurot.2024.e00457","article-title":"Microbiota modulation by teriflunomide therapy in people with multiple sclerosis: an observational case-control study","volume":"21","author":"Moles","year":"2024","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-64369-x","article-title":"Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosis","volume":"14","author":"Montgomery","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib61","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1186\/s12974-019-1611-4","article-title":"Immunomodulatory and anti-inflammatory effects of probiotics in multiple sclerosis: a systematic review","volume":"16","author":"Morshedi","year":"2019","journal-title":"J. Neuroinflammation"},{"issue":"4","key":"10.1016\/j.msard.2026.107948_bib62","first-page":"435","article-title":"Microbiota-driven mechanisms in multiple sclerosis: pathogenesis, therapeutic strategies, and biomarker potential","volume":"14","author":"Nemati","year":"2025","journal-title":"Biology. (Basel)"},{"key":"10.1016\/j.msard.2026.107948_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2020.108380","article-title":"Gut dysbiosis and multiple sclerosis","volume":"235","author":"Noto","year":"2022","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2026.107948_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106335","article-title":"Intestinal barrier dysfunction develops at the onset of experimental autoimmune encephalomyelitis, and can be induced by adoptive transfer of auto-reactive T cells","volume":"9","author":"Nouri","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.msard.2026.107948_bib65","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s12026-024-09471-y","article-title":"Involvement of gut microbiota in multiple sclerosis \u2014 review of a new pathophysiological hypothesis and potential treatment target","volume":"72","author":"Olejnik","year":"2024","journal-title":"Immunol. Res."},{"issue":"5","key":"10.1016\/j.msard.2026.107948_bib66","doi-asserted-by":"crossref","first-page":"4624","DOI":"10.3390\/ijerph20054624","article-title":"Changes in gut microbiota and multiple sclerosis: a systematic review","volume":"20","author":"Ordo\u00f1ez-Rodriguez","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.msard.2026.107948_bib67","doi-asserted-by":"crossref","first-page":"106","DOI":"10.15698\/mic2024.04.819","article-title":"The effect of multiple sclerosis therapy on gut microbiota dysbiosis: a longitudinal prospective study","volume":"11","author":"Paraschiv","year":"2024","journal-title":"Microb. Cell"},{"key":"10.1016\/j.msard.2026.107948_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.718220","article-title":"The gut\u2013brain axis in multiple sclerosis. Is its dysfunction a pathological trigger or a consequence of the disease?","volume":"12","author":"Parodi","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.msard.2026.107948_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2025.106913","article-title":"The effect of dietary interventions on peripheral markers of inflammation among people with multiple sclerosis: a systematic review and meta-analysis of randomized controlled trials","volume":"106","author":"Pingel","year":"2026","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"6","key":"10.1016\/j.msard.2026.107948_bib70","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5937\/arhfarm73-46986","article-title":"The microbiome\u2013gut\u2013brain axis in multiple sclerosis","volume":"73","author":"Radojevi\u0107","year":"2023","journal-title":"Arh. Farm."},{"issue":"17","key":"10.1016\/j.msard.2026.107948_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231710128","article-title":"How microbiota-derived metabolites link the gut to the brain during neuroinflammation","volume":"23","author":"Rebeaud","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.msard.2026.107948_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1652796","article-title":"The link between gut microbiota and multiple sclerosis from the perspective of barrier function","volume":"16","author":"Ren","year":"2025","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib73","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s12017-024-08783-4","article-title":"The role of gut-derived short-chain fatty acids in multiple sclerosis","volume":"26","author":"Saadh","year":"2024","journal-title":"Neuromolecular. Med."},{"issue":"6","key":"10.1016\/j.msard.2026.107948_bib74","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1111\/febs.17161","article-title":"Gut microbiota in multiple sclerosis and animal models","volume":"292","author":"Schumacher","year":"2025","journal-title":"FEBS. J."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib75","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s13063-025-09157-2","article-title":"Efficacy of diet on quality of life in multiple sclerosis (EDQ-MS): a study protocol for a randomized controlled clinical trial","volume":"26","author":"Shemirani","year":"2025","journal-title":"Trials"},{"issue":"2","key":"10.1016\/j.msard.2026.107948_bib76","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.intimp.2014.12.015","article-title":"A natural flavonoid glucoside icariin inhibits Th1 and Th17 cell differentiation and ameliorates experimental autoimmune encephalomyelitis","volume":"24","author":"Shen","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.msard.2026.107948_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.3593","article-title":"Causal effects of gut microbiota on multiple sclerosis: a two-sample Mendelian randomization study","volume":"14","author":"Sun","year":"2024","journal-title":"Brain Behav."},{"key":"10.1016\/j.msard.2026.107948_bib78","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.2147\/IDR.S254403","article-title":"The impact of gut microbiota disorders on the blood\u2013brain barrier","volume":"13","author":"Tang","year":"2020","journal-title":"Infect. Drug Resist."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-022-01148-1","article-title":"The gut microbiota in multiple sclerosis varies with disease activity","volume":"15","author":"Thirion","year":"2023","journal-title":"Genome Med."},{"key":"10.1016\/j.msard.2026.107948_bib80","doi-asserted-by":"crossref","DOI":"10.62958\/j.cjap.2025.014","article-title":"Perspectives on fecal microbiota transplantation: uses and modes of administration","author":"Tiwari","year":"2025","journal-title":"Chin. J. Appl. Physiol"},{"issue":"24","key":"10.1016\/j.msard.2026.107948_bib81","doi-asserted-by":"crossref","first-page":"7610","DOI":"10.3390\/jcm12247610","article-title":"Modulating the gut microbiome in multiple sclerosis management: a systematic review of current interventions","volume":"12","author":"Tsogka","year":"2023","journal-title":"J. Clin. Med."},{"issue":"19","key":"10.1016\/j.msard.2026.107948_bib82","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.3390\/nu17193068","article-title":"Precision nutrition and gut\u2013brain axis modulation in the prevention of neurodegenerative diseases","volume":"17","author":"Tuigunov","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.msard.2026.107948_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2023.578087","article-title":"The role of multiple sclerosis therapies on the dynamic of human gut microbiota","volume":"378","author":"Vacaras","year":"2023","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107948_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1514762","article-title":"The gut\u2013brain axis one year after treatment with cladribine tablets in patients with relapsing remitting multiple sclerosis: a pilot study","volume":"16","author":"van Pamelen","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.msard.2026.107948_bib85","doi-asserted-by":"crossref","DOI":"10.2196\/16162","article-title":"Alterations of gut microbiota and the brain\u2013immune\u2013intestine axis in patients with relapsing\u2013remitting multiple sclerosis after treatment with oral cladribine: protocol for a prospective observational study","volume":"9","author":"van Pamelen","year":"2020","journal-title":"JMIR Res. Protoc."},{"key":"10.1016\/j.msard.2026.107948_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119748","article-title":"Tripterygium glycoside tablets and triptolide alleviate experimental autoimmune encephalomyelitis mice involving the PACAP\/cAMP signaling pathway","volume":"347","author":"Wang","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"7","key":"10.1016\/j.msard.2026.107948_bib87","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2174\/1570159X19666210629145351","article-title":"Role of gut microbiota in multiple sclerosis and potential therapeutic implications","volume":"20","author":"Wang","year":"2022","journal-title":"Curr. Neuropharmacol."},{"issue":"3","key":"10.1016\/j.msard.2026.107948_bib88","doi-asserted-by":"crossref","first-page":"413","DOI":"10.36922\/an.413","article-title":"The gut microbiota and associated metabolites in multiple sclerosis","volume":"2","author":"Wang","year":"2023","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.msard.2026.107948_bib89","doi-asserted-by":"crossref","first-page":"4755","DOI":"10.2147\/DDDT.S510620","article-title":"Sheng-Jiang powder alleviates Th17\/treg immune imbalance of experimental autoimmune encephalomyelitis by regulating the fatty acids metabolism","volume":"19","author":"Wu","year":"2025","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.msard.2026.107948_bib90","article-title":"The role of the gut microbiota and fecal microbiota transplantation in neuroimmune diseases","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Neurol."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib91","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12987-025-00724-y","article-title":"Gut microbiota modulates CNS barrier function in murine model for multiple sclerosis","volume":"22","author":"Xie","year":"2025","journal-title":"Fluids. Barriers. CNS"},{"issue":"44","key":"10.1016\/j.msard.2026.107948_bib92","doi-asserted-by":"crossref","first-page":"E9318","DOI":"10.1073\/pnas.1615715114","article-title":"Gut dysbiosis breaks immunological tolerance toward the central nervous system during young adulthood","volume":"114","author":"Yadav","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"19","key":"10.1016\/j.msard.2026.107948_bib93","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914756","article-title":"Interaction of the gut microbiome and immunity in multiple sclerosis: impact of diet and immune therapy","volume":"24","author":"Yadav","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.msard.2026.107948_bib94","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2419689122","article-title":"Multiple sclerosis and gut microbiota: lachnospiraceae from the ileum of MS twins trigger MS-like disease in germ-free transgenic mice \u2014 an unbiased functional study","volume":"122","author":"Yoon","year":"2025","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.msard.2026.107948_bib95","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00284-022-03150-7","article-title":"Gastrointestinal tract, microbiota and multiple sclerosis (MS) and the link between gut microbiota and CNS","volume":"80","author":"Yousefi","year":"2023","journal-title":"Curr. Microbiol."},{"issue":"4","key":"10.1016\/j.msard.2026.107948_bib96","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12247-025-10065-w","article-title":"The effects of a novel supplement containing probiotics and vitamin D as an adjutant therapy on sNFL and Th cell profiles in patients with multiple sclerosis: a randomized, double-blind, placebo-controlled trial","volume":"20","author":"Zali","year":"2025","journal-title":"J. Pharm. Innov."},{"issue":"2","key":"10.1016\/j.msard.2026.107948_bib97","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.msard.2026.107948_bib98","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1080\/14737175.2023.2250919","article-title":"The role of fecal microbiota transplantation (FMT) in treating patients with multiple sclerosis","volume":"23","author":"Zhanel","year":"2023","journal-title":"Expert Rev. Neurother."},{"issue":"19","key":"10.1016\/j.msard.2026.107948_bib99","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1016\/j.cell.2022.08.021","article-title":"Gut microbiome of multiple sclerosis patients and paired household healthy controls reveal associations with disease risk and course","volume":"185","author":"Zhou","year":"2022","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.msard.2026.107948_bib100","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3390\/cells13060497","article-title":"Gut\u2013brain interactions and their impact on astrocytes in the context of multiple sclerosis and beyond","volume":"13","author":"Zi\u00dfler","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.msard.2026.107948_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175185","article-title":"Anemoside B4 ameliorates experimental autoimmune encephalomyelitis in mice by modulating inflammatory responses and the gut microbiota","volume":"931","author":"Zou","year":"2022","journal-title":"Eur. J. Pharmacol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009831?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826009831?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:28:27Z","timestamp":1792787307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826009831"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":101,"alternative-id":["S2211034826009831"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107948","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deconstructing the microbiota\u2013gut\u2013brain axis in multiple sclerosis: from a barrier\u2013immune\u2013metabolic framework to emerging therapeutics","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107948","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107948"}}